1. A.J. Lees, Apomorphine and Parkinson's disease, in: J.P.W.F. Lakke, E.M. Delhaas, A.W.F. Rutgers (Eds.), Parenteral Drug Therapy in Spasticity and Parkinson's Disease, The Parthenon Publishing Group, Carnforth, 1992, pp. 185–192.
2. J.L. Neumeyer, S. Law, R.J. Baldessarini, Historical highlights of the chemistry, pharmacology and early clinical uses of apomorphine, in: G.L. Gessa, G.U. Corsini (Eds.), Apomorphine and other Dopamimetics, Raven Press, New York, 1981, pp. 1–17.
3. R.J. Baldessarmni, G.W. Arana, N.S. Kula, A. Campbell, M. Harding, Preclinical studies of the pharmacology of aporphines, in: G.L. Gessa, G.U. Corsini (Eds.), Apomorphine and other Dopamimetics, Raven Press, New York, 1981, pp. 219–228.
4. Treatment of Parkinson's disease with apomorphines;Cotzias;N. Engl. J. Med.,1976
5. Absorption of apomorphine by various routes in parkinsonism;Gancher;Mov. Disord.,1991